Literature DB >> 10540019

A retrospective study of percutaneous endoscopic gastrostomy in ALS patients during the BDNF and CNTF trials.

E J Kasarskis1, D Scarlata, R Hill, C Fuller, N Stambler, J M Cedarbaum.   

Abstract

Percutaneous endoscopic gastrostomy (PEG) provides a reliable route for nutrition and hydration in ALS patients with dysphagia. We performed a retrospective analysis of the CNTF and BDNF databases to determine the clinical status of ALS patients within 30 days preceding PEG insertion. This analysis revealed an approximately 50% reduction of function across multiple measures of ALS disease status. A trend to earlier intervention with PEG was apparent upon review of published studies and the CNTF and BDNF studies. By comparing the rate of decline pre- and post-PEG, nutritional supplementation via PEG stabilized the weight loss experienced by patients. Death within 30 days post-PEG was associated with a marked reduction in forced vital capacity (FVC) and identified a group of ALS patients in whom PEG should be cautiously performed. These data emphasize the importance of sequential measurement of FVC in managing ALS patients to guide the timing of nutritional intervention with PEG.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10540019     DOI: 10.1016/s0022-510x(99)00230-0

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  24 in total

Review 1.  The management of motor neurone disease.

Authors:  P N Leigh; S Abrahams; A Al-Chalabi; M-A Ampong; L H Goldstein; J Johnson; R Lyall; J Moxham; N Mustfa; A Rio; C Shaw; E Willey
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-12       Impact factor: 10.154

2.  Diffusion tensor imaging of basal ganglia and thalamus in amyotrophic lateral sclerosis.

Authors:  Khema R Sharma; Sulaiman Sheriff; Andrew Maudsley; Varan Govind
Journal:  J Neuroimaging       Date:  2012-01-24       Impact factor: 2.486

Review 3.  Diagnostic investigation and multidisciplinary management in motor neuron disease.

Authors:  J A Rocha; C Reis; F Simões; J Fonseca; J Mendes Ribeiro
Journal:  J Neurol       Date:  2005-12       Impact factor: 4.849

4.  Percutaneous endoscopic gastrostomy in amyotrophic lateral sclerosis: a prospective observational study.

Authors:  Johannes Dorst; Luc Dupuis; Susanne Petri; Katja Kollewe; Susanne Abdulla; Joachim Wolf; Markus Weber; David Czell; Christian Burkhardt; Frank Hanisch; Stefan Vielhaber; Thomas Meyer; Gabriele Frisch; Dagmar Kettemann; Torsten Grehl; Bertold Schrank; Albert C Ludolph
Journal:  J Neurol       Date:  2015-01-25       Impact factor: 4.849

Review 5.  Trends in Research Literature Describing Dysphagia in Motor Neuron Diseases (MND): A Scoping Review.

Authors:  Ashley A Waito; Teresa J Valenzano; Melanie Peladeau-Pigeon; Catriona M Steele
Journal:  Dysphagia       Date:  2017-06-29       Impact factor: 3.438

6.  Safety and caregiver satisfaction with gastrostomy in patients with Ataxia Telangiectasia.

Authors:  Maureen A Lefton-Greif; Thomas O Crawford; Sharon McGrath-Morrow; Kathryn A Carson; Howard M Lederman
Journal:  Orphanet J Rare Dis       Date:  2011-05-15       Impact factor: 4.123

7.  Amyotrophic lateral sclerosis: early predictors of prolonged survival.

Authors:  Adam Czaplinski; Albert A Yen; Stanley H Appel
Journal:  J Neurol       Date:  2006-06-13       Impact factor: 4.849

Review 8.  Neurotrophic factors in neurodegenerative disorders : potential for therapy.

Authors:  Fabio Fumagalli; Raffaella Molteni; Francesca Calabrese; Paola Francesca Maj; Giorgio Racagni; Marco Andrea Riva
Journal:  CNS Drugs       Date:  2008       Impact factor: 5.749

9.  Frequency, timing and outcome of gastrostomy tubes for amyotrophic lateral sclerosis/motor neurone disease--a record linkage study from the Scottish Motor Neurone Disease Register.

Authors:  Raeburn B Forbes; Shuna Colville; Robert J Swingler
Journal:  J Neurol       Date:  2004-07       Impact factor: 4.849

Review 10.  Nutrition and dietary supplements in motor neuron disease.

Authors:  Jeffrey Rosenfeld; Amy Ellis
Journal:  Phys Med Rehabil Clin N Am       Date:  2008-08       Impact factor: 1.784

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.